217 related articles for article (PubMed ID: 17667884)
1. Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
Walker NE; Fasano MB; Hobbs RA; Horwitz PA
Crit Pathw Cardiol; 2007 Mar; 6(1):26-9. PubMed ID: 17667884
[TBL] [Abstract][Full Text] [Related]
2. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
Walker NE; Fasano MB; Horwitz PA
J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
5. Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Satish B; Tressa K; Harish CR
Crit Pathw Cardiol; 2007 Mar; 6(1):24-5. PubMed ID: 17667883
[TBL] [Abstract][Full Text] [Related]
6. Successful clopidogrel desensitization after drug-eluting stent implantation.
Kammer RT
J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
[TBL] [Abstract][Full Text] [Related]
7. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
[TBL] [Abstract][Full Text] [Related]
8. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Silberman S; Neukirch-Stoop C; Steg PG
Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel desensitization after drug-eluting stent placement.
von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
[TBL] [Abstract][Full Text] [Related]
10. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
Page NA; Schroeder WS
Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
[TBL] [Abstract][Full Text] [Related]
11. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerability of a clopidogrel desensitization protocol].
Estefanell-Tejero A; López-Cabezas C; Riu-Viladoms G; Falces-Salvador C
Med Clin (Barc); 2012 May; 138(15):684-5. PubMed ID: 22015006
[No Abstract] [Full Text] [Related]
13. Desensitization to clopidogrel: a growing need.
Sanchez-Lopez J; Muñoz-Cano R; Bartra J; Valero A; Picado C
Allergy; 2010 Feb; 65(2):279-80. PubMed ID: 19796212
[No Abstract] [Full Text] [Related]
14. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel (Plavix) desensitization: a case series.
Camara MG; Almeda FQ
Catheter Cardiovasc Interv; 2005 Aug; 65(4):525-7. PubMed ID: 15973671
[TBL] [Abstract][Full Text] [Related]
16. Isolated profound thrombocytopenia associated with clopidogrel.
Elmi F; Peacock T; Schiavone J
J Invasive Cardiol; 2000 Oct; 12(10):532-5. PubMed ID: 11022215
[TBL] [Abstract][Full Text] [Related]
17. Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.
Lokhandwala JO; Best PJ; Butterfield JH; Skelding KA; Scott T; Blankenship JC; Buckley JW; Berger PB
Circ Cardiovasc Interv; 2009 Aug; 2(4):348-51. PubMed ID: 20031738
[TBL] [Abstract][Full Text] [Related]
18. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel: who, when, and how?
Cannon CP
Rev Cardiovasc Med; 2007; 8 Suppl 3():S27-34. PubMed ID: 17917618
[TBL] [Abstract][Full Text] [Related]
20. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
Neubauer H; Lask S; Engelhardt A; Mügge A
Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
